Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

HGSI Will Take Massive Hit If Albiglutide, Darapladib Fail
Seeking Alpha
Saturday, April 14, 2012 - 12:19pm
tags:
Human Genome Sciences, albiglutide, darapladib, Emergent BioSolutions, diabetes, Biogen Idec, lupus
Spectrum Pharmaceuticals: A Strong Growth Stock In 2012
Motley Fool
Saturday, April 14, 2012 - 12:16pm
tags:
Spectrum Pharmaceuticals
Spectrum Will Sink Until 2013
Seeking Alpha
Saturday, April 14, 2012 - 12:11pm
tags:
Spectrum Pharmaceuticals
Tioga nabs $10M VC deal amid PhIII for bowel disorder drug
Fierce Biotech
Friday, April 13, 2012 - 10:51am
tags:
Tioga, venture capital, D-IBS, irritable bowel syndrome, Series B, asimadoline
Affymax gets Medicare payment code for Omontys
Yahoo/AP
Friday, April 13, 2012 - 10:47am
tags:
Affymax, Omontys, Medicare, anemia
Earnings Preview: Forest Laboratories
Forbes
Friday, April 13, 2012 - 10:02am
tags:
earnings, Forest Labs
Drugmakers Refuse To Back Down Over ALEC
Pharmalot
Friday, April 13, 2012 - 10:00am
tags:
ALEC, American Legislative Exchange Council
Shire scoops up Pervasis Therapeutics
Mass High Tech
Friday, April 13, 2012 - 9:59am
tags:
Pervasis Therapeutics, Shire, M&A, regenerative medicine
Novartis MS Patient Develops Rare Brain Disease
Pharmalot
Friday, April 13, 2012 - 9:57am
tags:
Gilenya, MS, multiple sclerosis, PML, Novartis
Celgene Riding Molecular Biology 'Revolution': CEO
CNBC
Friday, April 13, 2012 - 9:56am
tags:
Celegene, molecular biology, Robert Hugin
Forest Labs FY13 guidance likely to below consensus, says Goldman
The Fly on the Wall
Friday, April 13, 2012 - 9:55am
tags:
guidance, Forest Labs
Experts Divided on Texas Medical Board's Plan to Regulate Stem Cell Treatments
Science Now
Friday, April 13, 2012 - 9:54am
tags:
Texas, stem cells
Gilead Sciences' Hepatitis Drug in Spotlight at Major Medical Meeting
Minyanville
Friday, April 13, 2012 - 9:52am
tags:
hepatitis C, Gilead, GS-7977
Dendreon May See Massive Gains By 2013 On Provenge
Seeking Alpha
Friday, April 13, 2012 - 8:29am
tags:
Dendreon, Provenge, JNJ, Medivation, prostate cancer, Immunogen, Seattle Genetics
Why Idenix Pharmaceuticals Could Dive Further
Motley Fool
Friday, April 13, 2012 - 8:26am
tags:
Indenix, IDX184, hepatitis C
Keryx: Still Better Than Big Pharma
Motley Fool
Friday, April 13, 2012 - 8:24am
tags:
Keryx, perifosine
Big Pharma not big on scrapping health-care reform
Marketwatch
Friday, April 13, 2012 - 8:22am
tags:
healthcare reform, PhRMA
Rep overtime-pay issue will be argued at the Supreme Court next week
Pharmaceutical Commerce
Thursday, April 12, 2012 - 5:07pm
tags:
Supreme Court, overtime lawsuits
Johnson & Johnson Worst Days May Be Ahead Of It
Seeking Alpha
Thursday, April 12, 2012 - 12:27pm
tags:
JNJ
FDA adds clotting data to Bayer's Yaz, Yasmin
Fierce Pharma
Thursday, April 12, 2012 - 12:25pm
tags:
Bayer, FDA, Yaz, Yasmin, birth control pill

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.